DHC at a glance
DIVERSIFIED HEALTHCARE TRUST (DHC, SEC CIK 1075415) filed its latest 10-K annual report on February 24, 2026, a 10-Q quarterly report on August 3, 2026, an 8-K current report on August 3, 2026 and Form 4 insider filings as recently as September 21, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), DIVERSIFIED HEALTHCARE TRUST (DHC) reported revenue of $1.5 billion (up 2.8% from FY2024) and a net loss of $285.9 million. Diluted EPS was -$1.19.
- As of June 30, 2026, 31 institutional investment managers tracked by SignalX reported holding DIVERSIFIED HEALTHCARE TRUST (DHC) shares worth $676.8 million in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $1.5B
- +2.8% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 31 funds
- $676.8M · +1 vs prior quarter
- Latest 8-K
- Aug 3, 2026
- Item 2.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Core business model: Real estate investment trust specializing in senior housing, medical office, life science properties, and wellness centers
- Emphasis on energy efficiency and ESG initiatives via partnership with RMR and participation in ENERGY STAR and LEED programs
- No new segments introduced; focus on managing climate change impact and tenant cost pass-through measures
- Interest and other income $0 in 2025 and 2024, down from $1,581 in 2023 related to CARES and American Rescue Plan Act funds
- Noteworthy seasonal impact on senior housing earnings with lower Q1 and Q4 results, offset by stable tenant rent payments
Risk Factors
- Debt refinancing risk: $2.4B principal debt as of Dec 31, 2025, with exposure to high interest rates and potential covenant breaches limiting flexibility
- Geopolitical and macroeconomic exposure: impact from U.S. inflation, interest rate uncertainty, trade policies, tariffs, and economic downturns on real estate demand and tenant payments
- Operational risk: dependence on third-party managers to operate senior living communities, with limited recourse if performance or management transitions reduce cash flow
- Competitive risk: increasing labor costs and labor shortages pressuring senior living margins amid competition for qualified staff and wage inflation
- Regulatory risk: exposure to federal and state healthcare licensure, certification, and reimbursement laws with potential for civil and administrative penalties affecting revenues
Management Discussion & Analysis
- Revenue $875.5M with net loss $(305.4M) in 2025 vs $(370.3M) net loss in 2024; NOI $278.5M up from $258.9M (+7.5%)
- Operating margins: NOI growth from $258.9M to $278.5M; no direct margin % given but loss narrowed
- Best segment SHOP NOI $139.3M up 31% from $106.1M; worst Medical Office NOI $108.1M down 6.5% from $115.7M
- Cash flow: Operating cash used $(19.6M) vs provided $112.2M prior year; investing cash inflow $483.6M vs outflow $(187.0M); financing cash outflow $(492.0M) vs $(22.3M)
- Capital expenditures $146.0M in 2025 down from $190.5M; paid $9.7M in dividends; repaid senior notes due 2025 and 2026, issued $375M senior secured notes due 2030
- Outlook/risks: Focus on redevelopments, liquidity reliance on occupancy and rents; caution on inflation, labor shortages, rising costs, high interest rates, credit market access risks
AI summary of the DHC 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- NOI $84.443M, up from $70.132M YoY
- SHOP NOI $53.495M, up from $36.615M; Medical Office and Life Science NOI $23.709M, down from $26.487M
- Net loss $37.419M vs $91.639M YoY
- Operating cash flow $46.724M vs $49.777M; ending cash $136.196M vs $148.581M
- Headwinds: wage and commodity inflation, limited labor availability, potential redevelopment delays or higher costs
Risk Factors
- No material changes to previously disclosed 10-K risk factors
- Regulatory and compliance risks carried forward without quarterly updates
- Operational and competitive risks unchanged from the Annual Report
- Financial risks, including liquidity and debt maturities, unchanged from the Annual Report
AI summary of the DHC 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Q2 2026 results for quarter ended June 30, 2026
- Summary press release and detailed earnings presentation furnished as Exhibits 99.1 and 99.2
Item 5.07: Submission of Matters to a Vote of Security Holders
- All seven trustee nominees elected for one-year terms through the 2027 annual meeting
- Adam Portnoy and Jeffrey P. Somers received highest withhold totals, at 41,214,677 and 38,722,239 votes
Item 7.01: Regulation FD Disclosure
- Investor presentation posted June 1, 2026 under Regulation FD
- Exhibit 99.1 contains the presentation and may include updated operating or strategic information
AI summaries of DHC 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for DHC
Don't miss the next DHC filing
- Alerts as it files. A push when DHC files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut DHC, by share count.
- Ask anything. An AI agent that reads every DHC filing and answers with sources.
DHC alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| PORTNOY ADAM D. | F | Sep 17, 2026 | 19,315 | $8.13 |
| Brown Matthew C. | F | Sep 17, 2026 | 13,895 | $8.13 |
| Bilotto Christopher J. | F | Sep 17, 2026 | 25,118 | $8.13 |
| Bilotto Christopher J. | A | Sep 10, 2026 | 59,681 | - |
| PORTNOY ADAM D. | A | Sep 10, 2026 | 59,681 | - |
| Brown Matthew C. | A | Sep 10, 2026 | 53,050 | - |
| Neher Dawn K. | A | Jun 10, 2026 | 12,401 | - |
| Hollis Phyllis M. | A | Jun 10, 2026 | 12,401 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $1.4B | $1.5B | $1.5B | |
| Net Income | -$293.6M | -$370.3M | -$285.9M | |
| Net Margin | -20.8% | -24.8% | -18.6% | |
| Balance Sheet | ||||
| Total Assets | $5.4B | $5.1B | $4.4B | |
| Equity | $2.3B | $2.0B | $1.7B | |
| ROE | -12.6% | -18.9% | -17.2% | |
| Per Share | ||||
| EPS | $-1.23 | $-1.55 | $-1.19 | |
| Cash Flow | ||||
| Operating CF | $10.5M | $112.2M | -$19.6M | |
Source: XBRL data in DIVERSIFIED HEALTHCARE TRUST (DHC)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate DHC share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 31 | $676.8M |
| Q1 2026 | 30 | $465.6M |
| Q4 2025 | 27 | $313.2M |
| Q3 2025 | 24 | $280.4M |
| Q2 2025 | 27 | $232.7M |
| Q1 2025 | 23 | $121.3M |
| Q4 2024 | 18 | $106.6M |
| Q3 2024 | 18 | $121.5M |
- Vanguard Portfolio Management LLC+1.77M (+20%)
- Goldman Sachs Group+949.9K (+73%)
- Northern Trust+602.7K (+27%)
- Morgan Stanley+327.4K (+23%)
- Raymond James Financial+277.6K (+84%)
- Bank of America Corp−2.43M (-91%)
- BlackRock−802.5K (-3%)
- Prudential Financial−178.1K (-16%)
- Renaissance Technologies LLC−48.5K (-15%)
- BNY Mellon−14.0K (-1%)
- Franklin Resources+559.3K
- Citadel Advisors LLC+265.5K
- Millennium Management−43.6K
Source: 13F-HR filings on SEC EDGAR (aggregated from 198 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
DHC filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Sep 21, 2026 | - | - | - |
| 4 | Sep 21, 2026 | - | - | - |
| 4 | Sep 21, 2026 | - | - | - |
| 4 | Sep 14, 2026 | - | - | - |
| 4 | Sep 14, 2026 | - | - | - |
| 4 | Sep 14, 2026 | - | - | - |
| 10-Q | Aug 3, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 3, 2026 | - | Analysis | - |
| 4 | Jun 12, 2026 | - | - | - |
| 4 | Jun 12, 2026 | - | - | - |
| 4 | Jun 12, 2026 | - | - | - |
| 4 | Jun 12, 2026 | - | - | - |
| 8-K | Jun 12, 2026 | - | Analysis | - |
| 4 | Jun 12, 2026 | - | - | - |
| 4 | Jun 12, 2026 | - | - | - |
| 4 | Jun 12, 2026 | - | - | - |
| 8-K | Jun 1, 2026 | - | Analysis | |
| 8-K | May 5, 2026 | - | Analysis | - |
| 10-Q | May 4, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | May 4, 2026 | - | Analysis | - |
| 10-K | Feb 24, 2026 | Dec 31, 2025 | Analysis | |
| 8-K | Feb 24, 2026 | - | Analysis | - |
| 8-K | Feb 23, 2026 | - | Analysis | - |
| 8-K | Jan 14, 2026 | - | - | |
| 8-K | Jan 5, 2026 | - | - |
Related Real Estate companies
- AKR · ACADIA REALTY TRUSTReal Estate Investment Trusts
- ACR · ACRES Commercial Realty Corp.Real Estate Investment Trusts
- ADAM · ADAMAS TRUST, INC.Real Estate Investment Trusts
- ALX · ALEXANDERS INCReal Estate Investment Trusts
- ARE · Alexandria Real Estate EquitiesReal Estate Investment Trusts
- PINE · Alpine Income Property Trust, Inc.Real Estate Investment Trusts
- AAT · American Assets Trust, Inc.Real Estate Investment Trusts
- AHR · American Healthcare REIT, Inc.Real Estate Investment Trusts
DHC SEC filings: frequently asked questions
Which institutions hold DHC stock?
As of June 30, 2026, the largest DIVERSIFIED HEALTHCARE TRUST (DHC) holders among the 13F filers tracked by SignalX were BlackRock ($214.6 million), Vanguard Portfolio Management LLC ($98.5 million), Vanguard Capital Management LLC ($90.0 million), State Street Corp ($83.7 million), JPMorgan Chase & Co ($28.9 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was DHC's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), DIVERSIFIED HEALTHCARE TRUST (DHC) reported revenue of $1.5 billion (up 2.8% from FY2024) and a net loss of $285.9 million. Diluted EPS was -$1.19. The figures come from the XBRL data in the 10-K.
What are the main risks in DHC's latest 10-K?
In the 10-K filed February 24, 2026, DIVERSIFIED HEALTHCARE TRUST (DHC) flagged: Debt refinancing risk: $2.4B principal debt as of Dec 31, 2025, with exposure to high interest rates and potential covenant breaches limiting flexibility. Geopolitical and macroeconomic exposure: impact from U.S. inflation, interest rate uncertainty, trade policies, tariffs, and economic downturns on real estate demand and tenant payments. (AI summary of the Risk Factors section.)
What did DHC report in its latest 8-K?
DIVERSIFIED HEALTHCARE TRUST (DHC) filed an 8-K on August 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q2 2026 results for quarter ended June 30, 2026.
What are the latest DHC SEC filings?
DIVERSIFIED HEALTHCARE TRUST (DHC) filed its latest 10-K annual report on February 24, 2026, a 10-Q quarterly report on August 3, 2026, an 8-K current report on August 3, 2026 and a Form 4 insider filing on September 21, 2026.
What is DHC's SEC CIK number?
DIVERSIFIED HEALTHCARE TRUST (DHC)'s SEC Central Index Key (CIK) is 1075415. EDGAR lists every DHC filing under that number.
Ask anything about DHC
The research agent reads DHC's filings, financials, insider trades and 13F holders, then answers with sources.